Aclaris Therapeutics, Inc. - FORM S-1 - EX-23.1 - June 17, 2016

Attached files

file filename
EX-21.1 - Aclaris Therapeutics, Inc.acrs-20160617ex21165f894.htm
EX-10.25 - Aclaris Therapeutics, Inc.acrs-20160617ex102513ade.htm
EX-5.1 - Aclaris Therapeutics, Inc.acrs-20160617ex51ce04b29.htm
S-1 - Aclaris Therapeutics, Inc.acrs-20160617xs1.htm

Exhibit 23.1

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated March 23, 2016, relating to the financial statements, which appears in Aclaris Therapeutics, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2015.  We also consent to the reference to us under the heading “Experts” in such Registration Statement.

 

/s/ PricewaterhouseCoopers LLP

 

Philadelphia, Pennsylvania

June 17, 2016

 

Aclaris Therapeutics, Inc. Reports